EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Predisposing conditions in patients with small intestinal adenocarcinomas in the Netherlands: A 20‐year nationwide cohort study

Jasmijn D G Linssen iD, Pascale J M Schafrat, Tim R de Back, Felice N van Erning iD, Monique E van Leerdam, Evelien Dekker, Louis Vermeulen, Ignace H J T de Hingh, Dirkje W Sommeijer iD

International Journal of Cancer · 2025

DOI: 10.1002/ijc.35354 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift International Journal of Cancer, 2025. Verfasst von Jasmijn D G Linssen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Center Amsterdam, Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Amsterdam, The Nether…. Hauptthemen laut MEDLINE: Adenocarcinoma, Intestinal Neoplasms, Intestine, Small. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: KWF Kankerbestrijding, New York Stem Cell Foundation, Oncode Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Small intestinal adenocarcinomas (SIAs) are associated with predisposing conditions, including inflammatory bowel disease (IBD) and celiac disease, but also genetic syndromes such as Lynch syndrome (LS) and familial adenomatous polyposis (FAP). This nationwide cohort study investigated the incidence of genetic and non‐genetic predisposing conditions in SIA and their influence on tumor characteristics and clinical features. Data were obtained from the Netherlands Cancer Registry. The incidence, characteristics, and clinical features per predisposing condition were analyzed in 2697 SIA patients diagnosed from 1999 through 2019. Of all SIA patients, 5.6% were known to have a genetic predisposing syndrome, of whom 4.0% had LS and 1.6% had a polyposis syndrome. In addition, 6.8% of SIA patients had a non‐genetic predisposing condition: 3.9% IBD and 2.9% celiac disease. SIAs of patients with such predisposing syndromes or conditions were diagnosed at a younger age and earlier stage and affected the duodenum less often as compared to sporadic SIA patients. Both genetic and non‐genetic predisposing conditions were associated with significantly better overall survival (OS) compared to sporadic SIA: sporadic SIA (median OS: 13.0 months, 95% CI: 11.8–14.2), LS (213.1 months, 99.3–NA), polyposis syndromes (61.3 months, 19.7–NA), IBD (29.5 months, 20.3–69.8), and celiac disease (50.4 months, 24.6–124.7). This nationwide cohort study shows significant differences between SIA with and without predisposing conditions and highlights the need for research on underlying molecular mechanisms to improve outcomes of SIA patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdenocarcinomaIntestinal NeoplasmsIntestine, SmallHumansNetherlandsMaleFemaleMiddle AgedAdultAgedCohort StudiesGenetic Predisposition to DiseaseIncidenceAdenomatous Polyposis ColiCeliac DiseaseColorectal Neoplasms, Hereditary NonpolyposisRegistriesInflammatory Bowel DiseasesYoung AdultAged, 80 and over

Stichwörter der Autor:innen

incidencepredisposing conditionsprognosissmall intestinal adenocarcinoma

Autor:innen und Institutionen

  • Cancer Center Amsterdam, Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Amsterdam, The Netherlands.
  • Amsterdam Gastroenterology Endocrinology Metabolism, Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Amsterdam, The Netherlands.
  • Oncode Institute, Utrecht, The Netherlands.
  • Department of Gastroenterology and Hepatology, Amsterdam UMC, Location University of Amsterdam, Amsterdam, The Netherlands.
  • Department of Medical Oncology, Amsterdam UMC, Location University of Amsterdam, Amsterdam, The Netherlands.
  • Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands.

ORCID-Profile: Jasmijn D G Linssen, Felice N van Erning, Dirkje W Sommeijer

Förderung

  • KWF Kankerbestrijding
  • New York Stem Cell Foundation
  • Oncode Institute
  • ZonMw
  • European Research Council

Zitieren

APA

Linssen, J. D. G., Schafrat, P. J. M., de Back, T. R., van Erning, F. N., van Leerdam, M. E., Dekker, E., Vermeulen, L., de Hingh, I. H. J. T., & Sommeijer, D. W. (2025). Predisposing conditions in patients with small intestinal adenocarcinomas in the Netherlands: A 20‐year nationwide cohort study. International Journal of Cancer. https://doi.org/10.1002/ijc.35354

Vancouver

Linssen JDG, Schafrat PJM, de Back TR, van Erning FN, van Leerdam ME, Dekker E, et al. Predisposing conditions in patients with small intestinal adenocarcinomas in the Netherlands: A 20‐year nationwide cohort study. International Journal of Cancer. 2025. doi:10.1002/ijc.35354

BibTeX
@article{Linssen2025,
  author = {Linssen, Jasmijn D G and Schafrat, Pascale J M and de Back, Tim R and van Erning, Felice N and van Leerdam, Monique E and Dekker, Evelien and Vermeulen, Louis and de Hingh, Ignace H J T and Sommeijer, Dirkje W},
  title = {Predisposing conditions in patients with small intestinal adenocarcinomas in the Netherlands: A 20‐year nationwide cohort study},
  journal = {International Journal of Cancer},
  year = {2025},
  doi = {10.1002/ijc.35354}
}
Kostenlos starten →